Sheppard Mullin Expands Life Sciences Team in Del Mar
Sheppard, Mullin, Richter & Hampton LLP is pleased to announce that Scott E. Oross has joined the firm’s Del Mar office as a partner in the firm’s Corporate practice group and as a member of the Life Sciences and FDA industry team. Oross was most recently a partner at Paul Hastings. The addition of Oross follows that of partner Jing Liu and associate Paul Chang who joined the Life Sciences and FDA industry team in Del Mar last April.
“A number of our partners in Del Mar have known and worked with Scott over the years and his emerging company and venture capital experience are terrific fits for us,” said Sheppard Mullin Vice Chairman Jon Newby. “Bringing Scott on board will continue our strong growth in the life science sector which continues to be a priority for us.”
Commenting on Oross’ joining the firm, Jeralin Cardoso, Practice Group Leader of the firm’s Corporate Practice Group, said, “Scott is an accomplished attorney with experience ranging from assisting companies and investors through billion-dollar acquisitions to supporting emerging companies through venture financings and exits. His portfolio and background are terrific complements to our existing capabilities.”
Oross focuses his practice on emerging company and venture capital work, representing companies and investors in a number of different industries, with a primary focus on life sciences. His work includes a wide range of corporate transactions, including public and private offerings of equity and debt securities, mergers and acquisitions and strategic collaborations. He also regularly advises boards of directors and management on a variety of strategic and corporate governance issues.
He received his B.A. from the University of Notre Dame, summa cum laude, and his J.D. from Vanderbilt Law School, where he was a John W. Wade Scholar. Oross is currently a board member of Connect w/ San Diego Venture Group, the leading organization in San Diego that supports local entrepreneurs.